Header Logo

Connection

BEHRANG AMINI to Quinolines

Back to Details
This is a "connection" page, showing publications BEHRANG AMINI has written about Quinolines.
BEHRANG AMINI
Connection Strength
0.117
Quinolines
  1. Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol. 2017 Jun; 96(6):977-985.
    View in: PubMed
    Score: 0.117
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.